Psoriasis: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

  NCT07111494· Medical College of Wisconsin· Source

• A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

  NCT06095115· Janssen Research & Development, LLC· Source

• A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)

  NCT06220604· Janssen Research & Development, LLC· Source

• A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

  NCT06143878· Janssen Research & Development, LLC· Source

• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

  NCT06857942· Eli Lilly and Company· Source

• A Study of Guselkumab in Participants With Active Psoriatic Arthritis

  NCT04882098· Janssen Research & Development, LLC· Source

• A Study of Zasocitinib in Adults With Non-pustular Palmoplantar Psoriasis

  NCT07752108· Takeda· Source

• A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

  NCT06323356· Takeda· Source

• A Long-term Extension Study of Ustekinumab in Pediatric Participants

  NCT05092269· Janssen Research & Development, LLC· Source

• A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

  NCT07321873· Janssen Research & Development, LLC· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 28
• Mendelian Randomization Analysis 38
• CRISPR-Cas Systems 4
• Gene Expression Profiling 66
• Sequence Analysis, RNA 6
• Exome Sequencing 5
• Proteomics 24
• Metabolomics 13
• Flow Cytometry 11
• Immunohistochemistry 24
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 1
• Magnetic Resonance Imaging 23
• Machine Learning 27
• Deep Learning 4
• Cohort Studies 63
• Genome-Wide Association Study 38

• Deep learning-guided discovery of IL23/IL23R macromolecular inhibitors: An integrative framework combining virtual screening and experimental validation.

  Int J Biol Macromol, Jan 2026

• Comparative performance of deep learning models and non-dermatologists in diagnosing psoriasis, dermatophytosis, and eczema.

  Sci Rep, Dec 2025

• Using Artificial Intelligence to Automate the Analysis of Psoriasis Severity: A Pilot Study.

  Dermatology, Nov 2025

• Deep Learning for Diagnosis of Tinea Corporis and Tinea Cruris.

  J Cutan Med Surg, Nov 2025

See which targets of this disease your abstract mentions, and go to the people working on them.